Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD

115.19  +0.07 (+0.06%)

After market: 115.19 0 (0%)

Fundamental Rating

6

ADUS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. While ADUS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ADUS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ADUS was profitable.
In the past year ADUS had a positive cash flow from operations.
In the past 5 years ADUS has always been profitable.
ADUS had a positive operating cash flow in each of the past 5 years.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

ADUS's Return On Assets of 5.61% is amongst the best of the industry. ADUS outperforms 80.58% of its industry peers.
With a decent Return On Equity value of 7.94%, ADUS is doing good in the industry, outperforming 68.93% of the companies in the same industry.
The Return On Invested Capital of ADUS (6.56%) is better than 67.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADUS is below the industry average of 9.71%.
Industry RankSector Rank
ROA 5.61%
ROE 7.94%
ROIC 6.56%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

With an excellent Profit Margin value of 6.52%, ADUS belongs to the best of the industry, outperforming 83.50% of the companies in the same industry.
In the last couple of years the Profit Margin of ADUS has grown nicely.
The Operating Margin of ADUS (9.04%) is better than 78.64% of its industry peers.
In the last couple of years the Operating Margin of ADUS has grown nicely.
Looking at the Gross Margin, with a value of 32.56%, ADUS is in the better half of the industry, outperforming 60.19% of the companies in the same industry.
ADUS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.04%
PM (TTM) 6.52%
GM 32.56%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

ADUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ADUS has more shares outstanding than it did 1 year ago.
ADUS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ADUS is higher compared to a year ago.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 4.69 indicates that ADUS is not in any danger for bankruptcy at the moment.
ADUS has a better Altman-Z score (4.69) than 78.64% of its industry peers.
ADUS has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as ADUS would need 2.21 years to pay back of all of its debts.
ADUS's Debt to FCF ratio of 2.21 is amongst the best of the industry. ADUS outperforms 80.58% of its industry peers.
ADUS has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
ADUS has a Debt to Equity ratio of 0.20. This is in the better half of the industry: ADUS outperforms 66.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.21
Altman-Z 4.69
ROIC/WACC0.77
WACC8.48%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.74 indicates that ADUS should not have too much problems paying its short term obligations.
ADUS has a Current ratio of 1.74. This is in the better half of the industry: ADUS outperforms 63.11% of its industry peers.
A Quick Ratio of 1.74 indicates that ADUS should not have too much problems paying its short term obligations.
ADUS has a Quick ratio of 1.74. This is in the better half of the industry: ADUS outperforms 66.99% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.74% over the past year.
Measured over the past years, ADUS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.61% on average per year.
The Revenue has grown by 11.38% in the past year. This is quite good.
The Revenue has been growing by 12.22% on average over the past years. This is quite good.
EPS 1Y (TTM)14.74%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%17.36%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%20.29%

3.2 Future

ADUS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.72% yearly.
The Revenue is expected to grow by 8.83% on average over the next years. This is quite good.
EPS Next Y18.86%
EPS Next 2Y13.43%
EPS Next 3Y13.38%
EPS Next 5Y10.72%
Revenue Next Year21.33%
Revenue Next 2Y13.28%
Revenue Next 3Y11.23%
Revenue Next 5Y8.83%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.14 indicates a rather expensive valuation of ADUS.
Based on the Price/Earnings ratio, ADUS is valued a bit cheaper than the industry average as 68.93% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ADUS to the average of the S&P500 Index (27.15), we can say ADUS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 17.09, the valuation of ADUS can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 68.93% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.60. ADUS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.14
Fwd PE 17.09
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ADUS's Enterprise Value to EBITDA ratio is in line with the industry average.
61.16% of the companies in the same industry are more expensive than ADUS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.52
EV/EBITDA 17.97
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

ADUS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ADUS may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 13.38% in the coming years.
PEG (NY)1.12
PEG (5Y)1.27
EPS Next 2Y13.43%
EPS Next 3Y13.38%

0

5. Dividend

5.1 Amount

No dividends for ADUS!.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (6/30/2025, 8:00:00 PM)

After market: 115.19 0 (0%)

115.19

+0.07 (+0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners102.71%
Inst Owner Change1.49%
Ins Owners2.26%
Ins Owner Change3.94%
Market Cap2.12B
Analysts83.53
Price Target139.18 (20.83%)
Short Float %4.67%
Short Ratio4.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.46%
Min EPS beat(2)0.48%
Max EPS beat(2)4.43%
EPS beat(4)3
Avg EPS beat(4)3.31%
Min EPS beat(4)-0.68%
Max EPS beat(4)9%
EPS beat(8)7
Avg EPS beat(8)5.05%
EPS beat(12)10
Avg EPS beat(12)5.22%
EPS beat(16)12
Avg EPS beat(16)4.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.45%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.22%
Revenue beat(12)0
Avg Revenue beat(12)-1.5%
Revenue beat(16)0
Avg Revenue beat(16)-1.89%
PT rev (1m)0.56%
PT rev (3m)0.13%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)0.35%
EPS NY rev (1m)0.63%
EPS NY rev (3m)2.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.14%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-1.32%
Valuation
Industry RankSector Rank
PE 21.14
Fwd PE 17.09
P/S 1.75
P/FCF 23.52
P/OCF 21.92
P/B 2.13
P/tB N/A
EV/EBITDA 17.97
EPS(TTM)5.45
EY4.73%
EPS(NY)6.74
Fwd EY5.85%
FCF(TTM)4.9
FCFY4.25%
OCF(TTM)5.26
OCFY4.56%
SpS65.85
BVpS54.1
TBVpS-4.6
PEG (NY)1.12
PEG (5Y)1.27
Profitability
Industry RankSector Rank
ROA 5.61%
ROE 7.94%
ROCE 8.7%
ROIC 6.56%
ROICexc 7.11%
ROICexgc 99.98%
OM 9.04%
PM (TTM) 6.52%
GM 32.56%
FCFM 7.44%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexcg growth 3Y20.44%
ROICexcg growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score5
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.21
Debt/EBITDA 1.61
Cap/Depr 47.01%
Cap/Sales 0.54%
Interest Coverage 14.16
Cash Conversion 78.26%
Profit Quality 114.08%
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 4.69
F-Score5
WACC8.48%
ROIC/WACC0.77
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)14.74%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%17.36%
EPS Next Y18.86%
EPS Next 2Y13.43%
EPS Next 3Y13.38%
EPS Next 5Y10.72%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%20.29%
Revenue Next Year21.33%
Revenue Next 2Y13.28%
Revenue Next 3Y11.23%
Revenue Next 5Y8.83%
EBIT growth 1Y13.78%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year43.57%
EBIT Next 3Y17.53%
EBIT Next 5Y14.43%
FCF growth 1Y-18.04%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y-18%
OCF growth 3Y43.4%
OCF growth 5Y57.54%